Key Events and Timeline
- The company had originally scheduled a Board of Directors meeting for Saturday, 30th May 2026 to consider and approve the Standalone Audited Financial Results.
- In the initial disclosure (19th June 2026), the company stated the delay was due to a "medical exigency of the Statutory Auditor" which prevented the Statutory Auditor's Report from being available on time.
- Consequently, the board meeting was rescheduled to Tuesday, 2nd June 2026, and this change was duly intimated to the stock exchange.
- The company subsequently considered and approved the Standalone Audited Financial Results for Q4 and FY ended 31st March 2026 and submitted them to the exchange.
Correction and Updated Reason
In the supplemental disclosure dated 24th June 2026, the company corrects its previous statement. It clarifies that the delay was not due to the auditor's medical exigency but was actually "due to pending information/opinion/report to be submitted to the Auditors" by the company itself.
Company Assurance and Compliance
The company expressed regret for the delay and assured that "adequate measures have been implemented to ensure timely compliance with applicable provisions of SEBI (LODR) Regulations, 2015."